Accordingly, we observed a high fraction of CD161+ cells within overrepresented T cells in CLL patients and we found downregulation of CD1d on the surface of CLL cells, both in TCL1 mice and patients. The gene discussed is CD1D; the disease is B-cell chronic lymphocytic leukemia.